0001193125-26-391903 Sample Contracts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 15th, 2026 • Tempest Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 15th, 2026 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 11, 2026, between Tempest Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 15th, 2026 • Tempest Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 15th, 2026 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of September 11, 2026, by and between Tempest Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
SERIES [C] [D] COMMON STOCK PURCHASE WARRANT TEMPEST THERAPEUTICS, INC.Security Agreement • September 15th, 2026 • Tempest Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 15th, 2026 Company IndustryTHIS SERIES [C] [D] COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is the [six (6) year] / [three (3) year] anniversary of the date that is the later of the (i) Stockholder Approval Date and (ii) the Effectiveness Date (the “Termination Date”), but not thereafter, to subscribe for and purchase from Tempest Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PRE-FUNDED COMMON STOCK PURCHASE WARRANT TEMPEST THERAPEUTICS, INC.Pre-Funded Common Stock Purchase Warrant • September 15th, 2026 • Tempest Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 15th, 2026 Company IndustryTHIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Original Issuance Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Tempest Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
